The Second Window of Preconditioning (SWOP) where are we now?

Cardiovascular Drugs and Therapy

Volumn 24, Issue 3, 2010, Pages 235-254

  Hausenloy, Derek J ^a   Yellon, Derek M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardioprotection; Delayed ischemic preconditioning; Late ischemic preconditioning; Second window of cardioprotection

Indexed keywords

3 NITROPROPIONIC ACID; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 5 HYDROXYDECANOIC ACID; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BRADYKININ; CLAMIKALANT; CYCLOOXYGENASE 2; CYTOKINE; DELTA OPIATE RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GLYCERYL TRINITRATE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEME OXYGENASE 1; HYDROGEN SULFIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNINDEXED DRUG;

ACUTE HEART INFARCTION; ANGINA PECTORIS; CALCIUM TRANSPORT; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; DELAYED ISCHEMIC PRECONDITIONING; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXERCISE TOLERANCE; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART PACING; HEART PROTECTION; HEAT STRESS; HEMATOPOIETIC STEM CELL; HUMAN; HYPERLIPIDEMIA; ISCHEMIC PRECONDITIONING; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REPERFUSION INJURY; REVIEW; SECOND WINDOW OF PROTECTION; SIGNAL TRANSDUCTION; ST SEGMENT; STUNNED HEART MUSCLE; TRANSCRIPTION INITIATION; TRANSGENE; UNSTABLE ANGINA PECTORIS; VIRAL GENE THERAPY;

ANIMALS; CARDIOVASCULAR DISEASES; CYCLOOXYGENASE 2; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE II; TIME FACTORS;

EID: 78149337930     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-010-6237-9     Document Type: Review

References (194)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
2. Lawson CS, Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res. 1993;27:542-50.
3. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88:1264-72.
4. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293-9.
5. Szekeres L, Papp JG, Szilvassy Z, Udvary E, Vegh A. Moderate stress by cardiac pacing may induce both short term and long term cardioprotection. Cardiovasc Res. 1993;27:593-6.
6. Szekeres L. Drug-induced delayed cardiac protection against the effects of myocardial ischemia. Pharmacol Ther. 2005.
7. Baxter GF, Goma FM, Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 1997;92:159-67.
8. Currie RW, Karmazyn M, Kloc M, Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ Res. 1988;63:543-9.
9. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med. 1999;189:1699-706.
10. Domenech R, Macho P, Schwarze H, Sanchez G. Exercise induces early and late myocardial preconditioning in dogs. Cardiovasc Res. 2002;55:561-6.
11. Stambaugh K, Elliott GT, Jacobson KA, Liang BT. Additive effects of late preconditioning produced by monophosphoryl lipid A and the early preconditioning mediated by adenosine receptors and KATP channel. Circulation. 1999;99:3300-7.
12. Mullenheim J, Schlack W, Frassdorf J, Heinen A, Preckel B, Thamer V. Additive protective effects of late and early ischaemic preconditioning are mediated by the opening of KATP channels in vivo. Pflugers Arch. 2001;442:178-87.
13. Mullenheim J, Ebel D, Bauer M, Otto F, Heinen A, Frassdorf J, et al. Sevoflurane confers additional cardioprotection after ischemic late preconditioning in rabbits. Anesthesiology. 2003;99:624-31.
14. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285: H579-88.
15. Hausenloy DJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost. 2009;101:626-34.
16. Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, et al. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats. Am J Physiol Heart Circ Physiol. 2007;293: H2557-64.
17. Laude K, Beauchamp P, Thuillez C, Richard V. Endothelial protective effects of preconditioning. Cardiovasc Res. 2002;55:466-73.
18. Kaeffer N, Richard V, Thuillez C. Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals. Circulation. 1997;96:2311-6.
19. Laude K, Thuillez C, Richard V. Peroxynitrite triggers a delayed resistance of coronary endothelial cells against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2002;283: H1418-23.
20. Richard V, Danielou E, Kaeffer N, Thuillez C. Delayed endothelial protective effects of monophosphoryl lipid A after myocardial ischemia and reperfusion in rats. J Mol Cell Cardiol. 1999;31:1117-23.
21. Joyeux M, Bouchard JF, Lamontagne D, Godin-Ribuot D, Ribuot C. Heat stress-induced protection of endothelial function against ischaemic injury is abolished by ATP-sensitive potassium channel blockade in the isolated rat heart. Br J Pharmacol. 2000;130:345-50.
22. Loktionova SA, Ilyinskaya OP, Kabakov AE. Early and delayed tolerance to simulated ischemia in heat-preconditioned endothelial cells: a role for HSP27. Am J Physiol. 1998;275: H2147-58.
23. Laude K, Favre J, Thuillez C, Richard V. NO produced by endothelial NO synthase is a mediator of delayed preconditioninginduced endothelial protection. Am J Physiol Heart Circ Physiol. 2003;284: H2053-60.
24. Kim SJ, Zhang X, Xu X, Chen A, Gonzalez JB, Koul S, et al. Evidence for enhanced eNOS function in coronary microvessels during the second window of protection. Am J Physiol Heart Circ Physiol. 2007;292: H2152-8.
25. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87:893-9.
26. Li G, Labruto F, Sirsjo A, Chen F, Vaage J, Valen G. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase. Eur J Cardiothorac Surg. 2004;26:968-73.
27. Loukogeorgakis SP, Panagiotidou AT, Broadhead MW, Donald A, Deanfield JE, MacAllister RJ. Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system. J Am Coll Cardiol. 2005;46:450-6.
28. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-6.
29. Baxter GF, Marber MS, Patel VC, Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation. 1994;90:2993-3000.
30. Dana A, Baxter GF, Walker JM, Yellon DM. Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state. J Am Coll Cardiol. 1998;31:1142-9.
31. Maldonado C, Qiu Y, Tang XL, Cohen MV, Auchampach J, Bolli R. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. 1997;273: H1324-32.
32. Dana A, Skarli M, Papakrivopoulou J, Yellon DM. Adenosine A (1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase-and protein kinase C-dependent mechanism. Circ Res. 2000;86:989-97.
33. Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, et al. Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol. 2005;289: H2251-7.
34. Dana A, Jonassen AK, Yamashita N, Yellon DM. Adenosine A (1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation. 2000;101:2841-8.
35. Bernardo NL, Okubo S, Maaieh MM, Wood MA, Kukreja RC. Delayed preconditioning with adenosine is mediated by opening of ATP-sensitive K (+) channels in rabbit heart. Am J Physiol. 1999;277: H128-35. (Pubitemid 29354686)
36. Takano H, Bolli R, Black Jr RG, Kodani E, Tang XL, Yang Z, et al. A (1) or A (3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res. 2001;88:520-8. (Pubitemid 32240916)
37. Kodani E, Shinmura K, Xuan YT, Takano H, Auchampach JA, Tang XL, et al. Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors. Am J Physiol Heart Circ Physiol. 2001;281: H959-68.
38. Zhao TC, Kukreja RC. Late preconditioning elicited by activation of adenosine A (3) receptor in heart: role of NF-kappa B, iNOS and mitochondrial K (ATP) channel. J Mol Cell Cardiol. 2002;34:263-77.
39. Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ. Opioidinduced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res. 1999;84:846-51.
40. Gross ER, Peart JN, Hsu AK, Auchampach JA, Gross GJ. Extending the cardioprotective window using a novel deltaopioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am J Physiol Heart Circ Physiol. 2005;288: H2744-9.
41. Wu S, Li HY, Wong TM. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ Res. 1999;84:1388-95.
42. Chen M, Zhou JJ, Kam KW, Qi JS, Yan WY, Wu S, et al. Roles of KATP channels in delayed cardioprotection and intracellular Ca (2+) in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H. Br J Pharmacol. 2003;140:750-8.
43. Yu CK, Li YH, Wong GT, Wong TM, Irwin MG. Remifentanil preconditioning confers delayed cardioprotection in the rat. Br J Anaesth. 2007;99:632-8.
44. Patel HH, Hsu A, Moore J, Gross GJ. BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol. 2001;33:1455-65.
45. Wang GY, Zhou JJ, Shan J, Wong TM. Protein kinase C-epsilon is a trigger of delayed cardioprotection against myocardial ischemia of kappa-opioid receptor stimulation in rat ventricular myocytes. J Pharmacol Exp Ther. 2001;299:603-10.
46. Fryer RM, Hsu AK, Gross GJ. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol. 2001;96:136-42.
47. Zhou JJ, Pei JM, Wang GY, Wu S, Wang WP, Cho CH, et al. Inducible HSP70 mediates delayed cardioprotection via U-50488H pretreatment in rat ventricular myocytes. Am J Physiol Heart Circ Physiol. 2001;281: H40-7.
48. Patel HH, Hsu AK, Gross GJ. COX-2 and iNOS in opioidinduced delayed cardioprotection in the intact rat. Life Sci. 2004;75:129-40.
49. Jiang X, Shi E, Nakajima Y, Sato S. COX-2 mediates morphineinduced delayed cardioprotection via an iNOS-dependent mechanism. Life Sci. 2006;78:2543-9.
50. Jiang X, Shi E, Nakajima Y, Sato S, Ohno K, Yue H. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2. J Am Coll Cardiol. 2005;45:1707-15.
51. Liu J, Kam KW, Zhou JJ, Yan WY, Chen M, Wu S, et al. Effects of heat shock protein 70 activation by metabolic inhibition preconditioning or kappa-opioid receptor stimulation on Ca2+ homeostasis in rat ventricular myocytes subjected to ischemic insults. J Pharmacol Exp Ther. 2004;310:606-13.
52. Liu J, Kam KW, Borchert GH, Kravtsov GM, Ballard HJ, Wong TM. Further study on the role of HSP70 on Ca2+ homeostasis in rat ventricular myocytes subjected to simulated ischemia. Am J Physiol Cell Physiol. 2006;290: C583-91.
53. Patel HH, Hsu AK, Peart JN, Gross GJ. Sarcolemmal K (ATP) channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res. 2002;91:186-8.
54. Patel HH, Hsu A, Gross GJ. Delayed cardioprotection is mediated via a non-peptide delta opioid agonist, SNC-121, independent of opioid receptor stimulation. Basic Res Cardiol. 2004;99:38-45.
55. Kositprapa C, Ockaili RA, Kukreja RC. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol. 2001;33:1355-62.
56. Ebrahim Z, Yellon DM, Baxter GF. Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism. Am J Physiol Heart Circ Physiol. 2001;281: H1458-64.
57. Jaberansari MT, Baxter GF, Muller CA, Latouf SE, Roth E, Opie LH, et al. Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. J Am Coll Cardiol. 2001;37:1996-2001.
58. Yamashita N, Hoshida S, Otsu K, Taniguchi N, Kuzuya T, Hori M. The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol. 2000;131:415-22.
59. Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt G, et al. Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol. 2004;37:51-61.
60. Flaherty MP, Guo Y, Tiwari S, Rezazadeh A, Hunt G, Sanganalmath SK, et al. The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning. J Mol Cell Cardiol. 2008;45:735-41.
61. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res. 2004;64:61-71.
62. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest. 1996;97:562-76.
63. Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation. 1996;93:1177-84.
64. Gross ER, Peart JN, Hsu AK, Grover GJ, Gross GJ. K (ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K (ATP) channels, free radicals and MEK1/2. J Mol Cell Cardiol. 2003;35:985-92.
65. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52. (Pubitemid 27272981)
66. Qiu Y, Rizvi A, Tang XL, Manchikalapudi S, Takano H, Jadoon AK, et al. Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol. 1997;273: H2931-6.
67. Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidantsensitive mechanism. Circ Res. 1998;83:73-84. (Pubitemid 28322101)
68. Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol. 2000;279: H2360-71.
69. Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 1998;98:441-9.
70. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Bolli R. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSersignal transducers and activators of transcription1/3 pathway. Circulation. 2007;116:535-44.
71. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol. 2006;40:119-30.
72. Sivarajah A, McDonald MC, Thiemermann C. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat. Shock. 2006;26:154-61.
73. Hu LF, Pan TT, Neo KL, Yong QC, Bian JS. Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes. Pflugers Arch. 2008;455:971-8.
74. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, et al. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res. 2009;105:365-74.
75. Baxter GF, Goma FM, Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol. 1995;115:222-4.
76. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizvi A, Zhang J, et al. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest. 1998;101:2182-98.
77. Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res. 1999;84:587-604.
78. Xuan YT, Guo Y, Zhu Y, Wang OL, Rokosh G, Messing RO, et al. Role of the protein kinase C-{epsilon}-Raf-1-MEK-1/2-p44/42 MAPK signaling cascade in the activation of signal transducers and activators of transcription 1 and 3 and induction of cyclooxygenase-2 after ischemic preconditioning. Circulation. 2005.
79. Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, et al. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett. 1996;396:233-7.
80. Imagawa J, Baxter GF, Yellon DM. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol. 1997;29:1885-93.
81. Okubo S, Bernardo NL, Elliott GT, Hess ML, Kukreja RC. Tyrosine kinase signaling in action potential shortening and expression of HSP72 in late preconditioning. Am J Physiol Heart Circ Physiol. 2000;279: H2269-76.
82. Dawn B, Takano H, Tang XL, Kodani E, Banerjee S, Rezazadeh A, et al. Role of Src protein tyrosine kinases in late preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol. 2002;283: H549-56.
83. Tang XL, Kodani E, Takano H, Hill M, Shinmura K, Vondriska TM, et al. Protein tyrosine kinase signaling is necessary for NO donor-induced late preconditioning against myocardial stunning. Am J Physiol Heart Circ Physiol. 2003;284: H1441-8.
84. Dawn B, Xuan YT, Qiu Y, Takano H, Tang XL, Ping P, et al. Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. Circ Res. 1999;85:1154-63.
85. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, et al. PKCepsilon modulates NF-kappaB and AP-1 via mitogenactivated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol. 2000;279: H1679-89.
86. Samavati L, Monick MM, Sanlioglu S, Buettner GR, Oberley LW, Hunninghake GW. Mitochondrial K (ATP) channel openers activate the ERK kinase by an oxidant-dependent mechanism. Am J Physiol Cell Physiol. 2002;283: C273-81.
87. Bell RM, Clark JE, Hearse DJ, Shattock MJ. Reperfusion kinase phosphorylation is essential but not sufficient in the mediation of pharmacological preconditioning: characterisation in the biphasic profile of early and late protection. Cardiovasc Res. 2007;73:153-63.
88. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res. 2000;87:309-15.
89. Kis A, Yellon DM, Baxter GF. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol. 2003;35:1063-71.
90. Wang Y, Ahmad N, Kudo M, Ashraf M. Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning. Am J Physiol Heart Circ Physiol. 2004;287: H1125-31.
91. Xuan YT, Tang XL, Banerjee S, Takano H, Li RC, Han H, et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res. 1999;84:1095-109.
92. Wang Y, Kudo M, Xu M, Ayub A, Ashraf M. Mitochondrial K (ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide. J Mol Cell Cardiol. 2001;33:2037-46.
93. Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, et al. PKCepsilon modulates NF-kappaB and AP-1 via mitogenactivated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol. 2000;279: H1679-89.
94. Xuan YT, Guo Y, Zhu Y, Han H, Langenbach R, Dawn B, et al. Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J Mol Cell Cardiol. 2003;35:525-37.
95. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271-5.
96. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation. 2003;108:79-85.
97. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxiainducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem. 1999;274:32631-7.
98. Pore N, Jiang Z, Shu HK, Bernhard E, Kao GD, Maity A. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol Cancer Res. 2006;4:471-9.
99. Xi L, Taher M, Yin C, Salloum F, Kukreja RC. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am J Physiol Heart Circ Physiol. 2004;287: H2369-75.
100. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler III AA. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res. 2006;98:133-40.
101. Date T, Mochizuki S, Belanger AJ, Yamakawa M, Luo Z, Vincent KA, et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am J Physiol Cell Physiol. 2005;288: C314-20.
102. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol. 2005;46:2116-24.
103. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler III AA, et al. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am J Physiol Heart Circ Physiol. 2005;289: H542-8.
104. Nelson SK, Wong GH, McCord JM. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol. 1995;27:223-9.
105. Nogae C, Makino N, Hata T, Nogae I, Takahashi S, Suzuki K, et al. Interleukin 1 alpha-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat. J Mol Cell Cardiol. 1995;27:2091-9.
106. Eddy LJ, Goeddel DV, Wong GH. Tumor necrosis factor-alpha pretreatment is protective in a rat model of myocardial ischemiareperfusion injury. Biochem Biophys Res Commun. 1992;184:1056-9.
107. Hoshida S, Kuzuya T, Fuji H, Yamashita N, Oe H, Hori M, et al. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol. 1993;264: H33-9.
108. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest. 1994;94:2193-9.
109. Yamashita N, Hoshida S, Nishida M, Igarashi J, Taniguchi N, Tada M, et al. Heat shock-induced manganese superoxide dismutase enhances the tolerance of cardiac myocytes to hypoxiareoxygenation injury. J Mol Cell Cardiol. 1997;29:1805-13.
110. Zhai X, Zhou X, Ashraf M. Late ischemic preconditioning is mediated in myocytes by enhanced endogenous antioxidant activity stimulated by oxygen-derived free radicals. Ann N Y Acad Sci. 1996;793:156-66.
111. Li Q, Bolli R, Qiu Y, Tang XL, Murphree SS, French BA. Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation. 1998;98:1438-48.
112. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation. 2001;103:1893-8.
113. Yellon DM, Pasini E, Cargnoni A, Marber MS, Latchman DS, Ferrari R. The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. J Mol Cell Cardiol. 1992;24:895-907.
114. Tanaka M, Fujiwara H, Yamasaki K, Miyamae M, Yokota R, Hasegawa K, et al. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 h later in rabbits. Am J Physiol. 1994;267: H1476-82.
115. Sun JZ, Tang XL, Knowlton AA, Park SW, Qiu Y, Bolli R. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest. 1995;95:388-403.
116. Saganek LJ, Ignasiak DP, Batley BL, Potoczak RE, Dodd G, Gallagher KP. Heat stress increases cardiac HSP72i but fails to reduce myocardial infarct size in rabbits 24 hours later. Basic Res Cardiol. 1997;92:331-8.
117. Qian YZ, Bernardo NL, Nayeem MA, Chelliah J, Kukreja RC. Induction of 72-kDa heat shock protein does not produce second window of ischemic preconditioning in rat heart. Am J Physiol. 1999;276: H224-34.
118. Yin C, Salloum FN, Kukreja RC. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ Res. 2009;104:572-5.
119. Imagawa J, Yellon DM, Baxter GF. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning. Br J Pharmacol. 1999;126:701-8.
120. Kim SJ, Kim YK, Takagi G, Huang CH, Geng YJ, Vatner SF. Enhanced iNOS function in myocytes one day after brief ischemic episode. Am J Physiol Heart Circ Physiol. 2002;282: H423-8.
121. Xi L, Tekin D, Gursoy E, Salloum F, Levasseur JE, Kukreja RC. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol. 2002;283: H5-12.
122. Wang YP, Sato C, Mizoguchi K, Yamashita Y, Oe M, Maeta H. Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res. 2002;56:33-42.
123. Guo Y, Jones WK, Xuan YT, Tang XL, Bao W, Wu WJ, et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A. 1999;96:11507-12.
124. Zhao T, Xi L, Chelliah J, Levasseur JE, Kukreja RC. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A (1) receptors: evidence from gene-knockout mice. Circulation. 2000;102:902-7.
125. Xi L, Jarrett NC, Hess ML, Kukreja RC. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: evidence from pharmacological inhibition and gene knockout mice. Circulation. 1999;99:2157-63.
126. Tejero-Taldo MI, Gursoy E, Zhao TC, Kukreja RC. Alphaadrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart. J Mol Cell Cardiol. 2002;34:185-95.
127. Jiang X, Shi E, Nakajima Y, Sato S. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and geneknockout mice. Anesthesiology. 2004;101:82-8.
128. Jones WK, Flaherty MP, Tang XL, Takano H, Qiu Y, Banerjee S, et al. Ischemic preconditioning increases iNOS transcript levels in conscious rabbits via a nitric oxide-dependent mechanism. J Mol Cell Cardiol. 1999;31:1469-81.
129. West MB, Rokosh G, Obal D, Velayutham M, Xuan YT, Hill BG, et al. Cardiac myocyte-specific expression of inducible nitric oxide synthase protects against ischemia/reperfusion injury by preventing mitochondrial permeability transition. Circulation. 2008;118:1970-8.
130. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, et al. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res. 2002;90:602-8.
131. Wang Y, Kodani E, Wang J, Zhang SX, Takano H, Tang XL, et al. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2. Circ Res. 2004;95:84-91.
132. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci U S A. 2000;97:10197-202.
133. Kodani E, Xuan YT, Shinmura K, Takano H, Tang XL, Bolli R. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol. 2002;283: H1943-57. (Pubitemid 35217029)
134. Tang XL, Xuan YT, Zhu Y, Shirk G, Bolli R. Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol Heart Circ Physiol. 2004;286: H1273-80.
135. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology. 2004;100:525-31.
136. Alcindor D, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo. Anesthesiology. 2004;100:547-54.
137. Arnaud C, Joyeux-Faure M, Godin-Ribuot D, Ribuot C. COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning. Cardiovasc Res. 2003;58:582-8. (Pubitemid 36694444)
138. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954-9. (Pubitemid 33010342)
139. Shinmura K, Kodani E, Xuan YT, Dawn B, Tang XL, Bolli R. Effect of aspirin on late preconditioning against myocardial stunning in conscious rabbits. J Am Coll Cardiol. 2003;41:1183-94.
140. Shinmura K, Bolli R, Liu SQ, Tang XL, Kodani E, Xuan YT, et al. Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res. 2002;91:240-6.
141. Jancso G, Cserepes B, Gasz B, Benko L, Borsiczky B, Ferenc A, et al. Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning. Ann N Y Acad Sci. 2007;1095:251-61.
142. Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007;12:217-34.
143. Hanley PJ, Mickel M, Loffler M, Brandt U, Daut J. K (ATP) channel-independent targets of diazoxide and 5-hydroxydecanoate in the heart. J Physiol. 2002;542:735-41.
144. Hanley PJ, Daut J. K (ATP) channels and preconditioning: a reexamination of the role of mitochondrial K (ATP) channels and an overview of alternative mechanisms. J Mol Cell Cardiol. 2005;39:17-50.
145. Bernardo NL, D'Angelo M, Okubo S, Joy A, Kukreja RC. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart. Am J Physiol. 1999;276: H1323-30. (Pubitemid 29214148)
146. Mei DA, Elliott GT, Gross GJ. KATP channels mediate late preconditioning against infarction produced by monophosphoryl lipid A. Am J Physiol. 1996;271: H2723-9.
147. Hoag JB, Qian YZ, Nayeem MA, D'Angelo M, Kukreja RC. ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart. Am J Physiol. 1997;273: H2458-64.
148. Baxter GF, Yellon DM. ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation. J Mol Cell Cardiol. 1999;31:981-9.
149. Naderi R, Imani A, Faghihi M. Phenylephrine produces late pharmacological preconditioning in the isolated rat heart. Eur J Pharmacol. 2009.
150. Basgut B, Aypar E, Basgut E, Akin KO, Kilic N, Cakici I. The mechanism of the late preconditioning effect of 3-nitropropionic acid. Arch Pharm Res. 2008;31:1257-63.
151. Patel HH, Gross ER, Peart JN, Hsu AK, Gross GJ. Sarcolemmal KATP channel triggers delayed ischemic preconditioning in rats. Am J Physiol Heart Circ Physiol. 2005;288: H445-7.
152. Ockaili R, Emani VR, Okubo S, Brown M, Krottapalli K, Kukreja RC. Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol. 1999;277: H2425-34.
153. Xu W, Liu Y, Wang S, McDonald T, Van Eyk JE, Sidor A, et al. Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane. Science. 2002;298:1029-33.
154. Wang X, Yin C, Xi L, Kukreja RC. Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice. Am J Physiol Heart Circ Physiol. 2004;287: H2070-7.
155. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol. 2003;35:339-41.
156. Hausenloy DJ, Maddock HL, Baxter GF, Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res. 2002;55:534-43.
157. Hausenloy DJ, Yellon DM. Adenosine-induced second window of protection is mediated by inhibition of mitochondrial permeability transition pore opening at the time of reperfusion. Cardiovasc Drugs Ther. 2004;18:79-80.
158. Rajesh KG, Sasaguri S, Zhitian Z, Suzuki R, Asakai R, Maeda H. Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression. Cardiovasc Res. 2003;59:297-307.
159. Li Q, Guo Y, Xuan YT, Lowenstein CJ, Stevenson SC, Prabhu SD, et al. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res. 2003;92:741-8.
160. Bolli R, Li QH, Tang XL, Guo Y, Xuan YT, Rokosh G, et al. The late phase of preconditioning and its natural clinical applicationgene therapy. Heart Fail Rev. 2007;12:189-99.
161. Haider HK, Ashraf M. Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol. 2008;45:554-66.
162. Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, Asahara T, et al. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation. 2007;27:1403-10.
163. Kamota T, Li TS, Morikage N, Murakami M, Ohshima M, Kubo M, et al. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol. 2009;53:1814-22.
164. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2005;288: H1252-6.
165. Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol. 2009;6:419-29.
166. Yin C, Wang X, Kukreja RC. Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemiareperfusion in mice. FEBS Lett. 2008;582:4137-42.
167. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007;59:418-58.
168. Ludman A, Yellon DM, Hausenloy DJ. Cardiac preconditioning for ischaemia: lost in translation. Disease Models & Mechanisms. 2010. In Press.
169. Szekeres L, Szilvassy Z, Ferdinandy P, Nagy I, Karcsu S, Csati S. Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits. J Mol Cell Cardiol. 1997;29:1977-83.
170. Wang C, Chiari PC, Weihrauch D, Krolikowski JG, Warltier DC, Kersten JR, et al. Gender-specificity of delayed preconditioning by isoflurane in rabbits: potential role of endothelial nitric oxide synthase. Anesth Analg. 2006;103:274-80. table.
171. Shinmura K, Nagai M, Tamaki K, Bolli R. Gender and aging do not impair opioid-induced late preconditioning in rats. Basic Res Cardiol. 2004;99:46-55.
172. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: the importance of akt phosphorylation. Diabetes. 2005;54:2360-4.
173. Qi JS, Kam KW, Chen M, Wu S, Wong TM. Failure to confer cardioprotection and to increase the expression of heat-shock protein 70 by preconditioning with a kappa-opioid receptor agonist during ischaemia and reperfusion in streptozotocininduced diabetic rats. Diabetologia. 2004;47:214-20.
174. Negroni JA, Lascano EC, del Valle HF, Crottogini AJ. ATP-sensitive potassium channels do not have a main role in mediating late preconditioning protection against arrhythmias and stunning in conscious sheep. Basic Res Cardiol. 2002;97:55-64.
175. Del Valle HF, Lascano EC, Negroni JA, Crottogini AJ. Absence of ischemic preconditioning protection in diabetic sheep hearts: role of sarcolemmal KATP channel dysfunction. Mol Cell Biochem. 2003;249:21-30.
176. Stein AB, Tang XL, Guo Y, Xuan YT, Dawn B, Bolli R. Delayed adaptation of the heart to stress: late preconditioning. Stroke. 2004;35:2676-9.
177. Tang XL, Takano H, Xuan YT, Sato H, Kodani E, Dawn B, et al. Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin- dependent mechanism in conscious rabbits. Circulation. 2005;112:2149-56.
178. Feng J, Lucchinetti E, Fischer G, Zhu M, Zaugg K, Schaub MC, et al. Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB. Cardiovasc Res. 2008;78:98-107.
179. Ghosh S, Ng LL, Talwar S, Squire IB, Galinanes M. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc Res. 2000;48:440-7.
180. Ghosh S, Standen NB, Galinanes M. Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res. 2000;45:339-50.
181. Loubani M, Hassouna A, Galinanes M. Delayed preconditioning of the human myocardium: signal transduction and clinical implications. Cardiovasc Res. 2004;61:600-9.
182. Tomai F, Perino M, Ghini AS, Crea F, Gaspardone A, Versaci F, et al. Exercise-induced myocardial ischemia triggers the early phase of preconditioning but not the late phase. Am J Cardiol. 1999;83:586-8.
183. Bilinska M, Rudnicki S, Beresewicz A. Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection? Basic Res Cardiol. 2000;95:418-23.
184. Jneid H, Chandra M, Alshaher M, Hornung CA, Tang XL, Leesar M, et al. Delayed preconditioning-mimetic actions of nitroglycerin in patients undergoing exercise tolerance tests. Circulation. 2001;103:2935-41.
185. Lambiase PD, Edwards RJ, Cusack MR, Bucknall CA, Redwood SR, Marber MS. Exercise-induced ischemia initiates the second window of protection in humans independent of collateral recruitment. J Am Coll Cardiol. 2003;41:1174-82.
186. Gori T, Di Stolfo G, Sicuro S, Dragoni S, Lisi M, Forconi S, et al. Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol. 2007;64:145-50.
187. Hausenloy D, Wynne A, Duchen M, Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation. 2004;109:1714-7.
188. Noda T, Minatoguchi S, Fujii K, Hori M, Ito T, Kanmatsuse K, et al. Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1966-74.
189. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol. 2001;38:1007-11.
190. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Ueda K, et al. Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am Heart J. 2000;139:881-8.
191. Vahlhaus C, Neumann J, Luss H, Wenzelburger F, Tjan TD, Hammel D, et al. Ischemic preconditioning by unstable angina reduces the release of CK-MB following CABG and stimulates left ventricular HSP-72 protein expression. J Card Surg. 2005;20:412-9.
192. Wang Y, Yin B, Liu S, Xue S. Cardioprotective effect by tumor necrosis factor-alpha and interleukin-6 through late preconditioning in unstable angina patients. Arch Med Res. 2007;38:80-5.
193. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370:575-9.
194. Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, et al. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation. 2009;119:820-7.